ARTICLE | Clinical News
Apocept: Additional Phase II data
February 17, 2014 8:00 AM UTC
Additional data from an open-label, international Phase II trial in 84 patients with recurrent GBM showed that once-weekly IV APG101 plus radiotherapy as second-line treatment significantly improved m...